drugset / Trial / NCT00507546
Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
Phase 4
Completed
12 enrolled
US Department of Veterans Affairs
Stanford University · collabTakeda · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine if replacing melatonin function with a melatonin agonist (ramelteon) in individuals that lack endogenous melatonin production (tetraplegia) helps to alleviate self-reported sleep disruption.
Timeline
- Start
- 2007-07
- Primary completion
- 2010-12
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 8 mg | — |